COMP <GO>
CSBR vs CGTX // EV/EBITDA & P/E VALUATION
Champions Oncology Inc. (NASDAQ) VS. Cognition Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CSBR 2
— CGTX 1
■ METRIC PARITY
LAST: $4.81 (0.00%) • MKT CAP: $66.9M
valuation
—
LAST: $0.70 (-5.57%) • MKT CAP: $70.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSBR VS. CGTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CSBR | CGTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -26.90% | -35.00% | +8.10 | CSBR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.52% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -1.90% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 0.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 4.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.7 | 33.0 | +13.71 | CSBR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $66.9M | $70.3M | -$3.4M | CGTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CSBR REV | CGTX REV | CSBR GROSS % | CGTX GROSS % | CSBR FCF | CGTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $59.4M | $0 | 48.0% | — | -$5.0M | -$24.6M |
| FY 2024 | $56.9M | $0 | 50.1% | — | $7.0M | -$28.5M |
| FY 2023 | $50.2M | $0 | — | — | -$6.1M | -$16.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSBR // BETA —
CGTX // BETA —